<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01901419</url>
  </required_header>
  <id_info>
    <org_study_id>TSGHIRB 1-102-05-049</org_study_id>
    <nct_id>NCT01901419</nct_id>
  </id_info>
  <brief_title>Nitroglycerin Infusion During Cardiac Surgery</brief_title>
  <official_title>Nitroglycerin Infusion During Rewarming in Cardiac Surgery and Its Effects on Tissue Perfusion and Coagulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tri-Service General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tri-Service General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothermic cardiopulmonary bypass results in peripheral vasoconstriction and heparin
      trapping. Hypoperfusion and ischemic-reperfusion injury are associated with systemic
      inflammatory response, while insufficient and delayed neutralization of heparin by protamine
      may contribute to more blood loss during rewarming stage.

      Nitroglycerin infusion, an NO-related vasodilator, is an established and effective treatment
      for unstable angina, myocardial infarction, congestive heart failure, and perioperative
      hemodynamic management for cardiac surgery. Therefore, we hypothesize that nitroglycerin
      infusion during rewarming corrects systemic ischemic stress and facilitates heparin
      neutralization in cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized clinical trial in a tertiary academic center in patients with cardiac surgery,
      to receive either nitroglycerin infusion dose of 0-0.1 mcg/kg/min, or 1-5 mcg/kg/min during
      rewarming in cardiopulmonary bypass.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma lactate level</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perioperative blood loss</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>one year</time_frame>
    <description>To keep mean blood pressure 50-80 mmHg during cardiopulmonary bypass.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inotropic doses</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Brain oximetry values</measure>
    <time_frame>one year</time_frame>
    <description>Values decreasing to 50 or less need interventions.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Lactic Acidosis</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>High-dose NTG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nitroglycerin infusion 1-5 mcg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-dose NTG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nitroglycerin infusion 0-0.1 mcg/kg/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin infusion</intervention_name>
    <description>Nitroglycerin infusion during rewarming</description>
    <arm_group_label>High-dose NTG</arm_group_label>
    <arm_group_label>Low-dose NTG</arm_group_label>
    <other_name>Millisrol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cardiac surgery

        Exclusion Criteria:

          -  heart failure, respiratory failure, asthma attack, uremia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tso-Chou Lin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tri-Service General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tso-Chou Lin, MD</last_name>
    <phone>+886287923311</phone>
    <phone_ext>12907</phone_ext>
    <email>tclin@ndmctsgh.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tri-Service General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>114</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tso-Chou Lin</last_name>
      <phone>+886287923311</phone>
      <phone_ext>12907</phone_ext>
      <email>tclin@ndmctsgh.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Tso-Chou Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Piquette D, Deschamps A, BÃ©lisle S, Pellerin M, Levesque S, Tardif JC, Denault AY. Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery. Can J Anaesth. 2007 Sep;54(9):718-27.</citation>
    <PMID>17766739</PMID>
  </reference>
  <reference>
    <citation>Masoumi G, Pour EH, Sadeghpour A, Ziayeefard M, Alavi M, Anbardan SJ, Shirani S. Effect of different dosages of nitroglycerin infusion on arterial blood gas tensions in patients undergoing on- pump coronary artery bypass graft surgery. J Res Med Sci. 2012 Feb;17(2):123-7.</citation>
    <PMID>23264783</PMID>
  </reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2013</study_first_submitted>
  <study_first_submitted_qc>July 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2013</study_first_posted>
  <last_update_submitted>July 13, 2013</last_update_submitted>
  <last_update_submitted_qc>July 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tri-Service General Hospital</investigator_affiliation>
    <investigator_full_name>Tso-Chou Lin</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>nitroglycerin</keyword>
  <keyword>cardiopulmonary bypass</keyword>
  <keyword>cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Acidosis, Lactic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

